Search results for the

From midnight on 1st April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs, under the Misuse of Drugs Regulations (2001), and Class C of the Misuse of Drugs Act (1971)

Today we have launched a consultation which outlines proposed changes to the Standards of conduct, performance and ethics.

The HCPC, in collaboration with eight other professional health and care regulators, has published the latest Whistleblowing disclosures report for 2024.

The HCPC offices will be closed on Monday 26 August for the summer bank holiday weekend

This report explores the ethical experiences of practitioners working in health and social care professions and was commissioned by the Authority from Professor Deborah Bowman.

Key findings from our year in registration survey, which aims to gather insight about how students’ education and training prepares them for practice. 

In early 2017, the HCPC commenced a review of the Indicative Sanctions Policy to ensure it is up to date, reflects public opinion, and continues to support fair and proportionate decision making. As part of this review we commissioned market research into the public’s views of the Policy and undertook a public consultation.

Continuing professional development (CPD) should improve your work and have a positive impact for your service users

The Health and Care Professions Council has recently revised our standards for prescribing, following a public consultation. The revised standards took effect on 1 September 2019.